Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

LLS and Forma to develop new therapies for diffuse large B-cell lymphoma

March 17, 2010

Sigma-Aldrich to sell Pfizer's small-molecule compounds to researchers

March 16, 2010

Orexigen and Patheon enter into exclusive manufacturing agreement for Contrave

March 16, 2010

Eisai and Johns Hopkins to collaborate on development GCPII inhibitors

March 16, 2010

Ipsen grants Rhythm worldwide license for two programs in metabolic disorders

March 15, 2010

Trillium expands immunology pipeline and enters stem cell field

March 15, 2010

Medivir outlicenses hepatitis B therapeutic MIV-210 to Daewoong

March 12, 2010

BioInvent and Human Genome Sciences enter collaboration for monoclonal antibodies

March 12, 2010

Biomoda and Obio collaborate to expand lung cancer screening program

March 12, 2010

Affymax receives milestone payment from Takeda for phase III Hematide trial in Japan

March 11, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...